RecruitingPhase 1NCT07078929

Clinical Trial of CMD63 Chimeric Antigen Receptor T-cell (CAR T-cell) in Children With Acute Lymphoblastic Leukemia (ALL)

Studying Acute lymphoblastic leukemia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chulalongkorn University
Principal Investigator
Kanhatai Chiengthong, MD
King Chulalongkorn Memorial Hospital
Intervention
CD19-IL7Ra CAR-T cells(biological)
Enrollment
16 enrolled
Eligibility
1-18 years · All sexes
Timeline
20262028

Study locations (3)

Collaborators

King Chulalongkorn Memorial Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07078929 on ClinicalTrials.gov

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

See all trials for Acute lymphoblastic leukemia

← Back to all trials